PHIO’s Board Gets a Major Boost with New Lead Independent Director—What Does Deming’s Appointment Mean for Its Cancer Gene Silencing Ambitions?
Market Chameleon (Mon, 3-Nov 9:53 AM)
PHIO’s PH-762 Trial Hits Maximum Dose with Positive Responses: Complete Tumor Clearance Observed in Skin Cancer Patients
Market Chameleon (Mon, 3-Nov 8:23 AM)
